CWG
C WorldWide Group Portfolio holdings
AUM
$7.38B
This Quarter Return
+5.2%
1 Year Return
+18.35%
3 Year Return
+71.53%
5 Year Return
+105.42%
10 Year Return
+360.65%
AUM
$6.92B
AUM Growth
+$6.92B
(-1.7%)
Cap. Flow
-$368M
Cap. Flow
% of AUM
-5.32%
Top 10 Holdings %
Top 10 Hldgs %
73.6%
Holding
128
New
2
Increased
25
Reduced
68
Closed
5
Top Buys
| 1 |
Visa
V
|
$14.1M |
| 2 |
Citigroup
C
|
$10.4M |
| 3 |
Ecolab
ECL
|
$9.84M |
| 4 |
Home Depot
HD
|
$9.17M |
| 5 |
Amazon
AMZN
|
$9.13M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$283M |
| 2 |
Meta Platforms (Facebook)
META
|
$53.9M |
| 3 |
Alphabet (Google) Class C
GOOG
|
$44.1M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$12.8M |
| 5 |
Teva Pharmaceuticals
TEVA
|
$5.74M |
Sector Composition
| 1 | Financials | 30.75% |
| 2 | Consumer Discretionary | 19.53% |
| 3 | Communication Services | 15.03% |
| 4 | Healthcare | 13.85% |
| 5 | Materials | 7.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Vertex Pharmaceuticals
VRTX
$102B
| $7.28M | 0.11% |
48,588
+10,442
| +27% | +$1.56M |
|
52
Zimmer Biomet
ZBH
$20.6B
| $7.2M | 0.1% |
59,639
| – | – |
|
53
Jazz Pharmaceuticals
JAZZ
$7.96B
| $6.69M | 0.1% |
49,654
-297
| -0.6% | -$40K |
|
54
Sarepta Therapeutics
SRPT
$1.94B
| $5.59M | 0.08% |
100,478
-21,991
| -18% | -$1.22M |
|
|
NUVA
55
DELISTED
NuVasive, Inc.
NUVA
| $5.41M | 0.08% |
92,444
-2,383
| -3% | -$139K |
|
|
PTLA
56
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $5.1M | 0.07% |
104,671
-18,130
| -15% | -$883K |
|
57
BioMarin Pharmaceuticals
BMRN
$11.3B
| $5.05M | 0.07% |
56,680
-32,292
| -36% | -$2.88M |
|
|
HZNP
58
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $5.01M | 0.07% |
342,894
-40,254
| -11% | -$588K |
|
|
AERI
59
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $4.91M | 0.07% |
82,188
-7,196
| -8% | -$430K |
|
60
Incyte
INCY
$17B
| $4.75M | 0.07% |
50,176
-25,765
| -34% | -$2.44M |
|
|
AIMT
61
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $4.68M | 0.07% |
123,700
-107,200
| -46% | -$4.05M |
|
|
KTWO
62
DELISTED
K2M Group Holdings, Inc
KTWO
| $4.17M | 0.06% |
231,368
+30,176
| +15% | +$543K |
|
63
DexCom
DXCM
$30.1B
| $4.11M | 0.06% |
71,687
+14,852
| +26% | +$852K |
|
|
XENT
64
DELISTED
Intersect ENT, Inc
XENT
| $4.08M | 0.06% |
125,890
-20,836
| -14% | -$675K |
|
|
DERM
65
DELISTED
Dermira, Inc.
DERM
| $3.92M | 0.06% |
141,062
-11,999
| -8% | -$334K |
|
66
NovoCure
NVCR
$1.34B
| $3.85M | 0.06% |
190,800
-39,700
| -17% | -$802K |
|
|
GWPH
67
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $3.85M | 0.06% |
29,190
-2,673
| -8% | -$353K |
|
68
Exact Sciences
EXAS
$9.25B
| $3.85M | 0.06% |
73,310
-79,820
| -52% | -$4.19M |
|
69
Ultragenyx Pharmaceutical
RARE
$3.07B
| $3.31M | 0.05% |
71,440
-6,251
| -8% | -$290K |
|
|
TVRD
70
Tvardi Therapeutics, Inc. Common Stock
TVRD
$272M
| $3.27M | 0.05% |
267,416
-23,925
| -8% | -$293K |
|
|
ITCI
71
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $3.22M | 0.05% |
222,510
-19,646
| -8% | -$284K |
|
72
Open Text
OTEX
$8.33B
| $3.1M | 0.04% |
69,300
+20,600
| +42% | +$921K |
|
|
STML
73
DELISTED
Stemline Therapeutics, Inc.
STML
| $3.05M | 0.04% |
195,437
+35,437
| +22% | +$553K |
|
74
TJX Companies
TJX
$155B
| $2.78M | 0.04% |
36,300
+19,200
| +112% | +$1.47M |
|
75
Toronto Dominion Bank
TD
$128B
| $2.75M | 0.04% |
37,332
| – | – |
|